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Abstract
Objective: This study set out to investigate the relationship between molecular-genetic mechanisms that
modulate cytokine in infants whose parents expose them to cigarette smoke and those that do not expose their
infants to cigarette smoke with the possible effects on the severity of pneumonia at presentation to hospital.
Methods: This cross sectional study recruited infants and parents from a regional Children’s Hospital. The infants
where classified into three groups:
1. Where the infant was exposed to cigarette smoke through the mother directly (N=50).
2. The mother did not smoke but the infant was exposed to tobacco smoke from the relatives in the family (N=50).
3. The infant was in a family in which no one smoked. Analysis of genetic polymorphisms (regional frequencies)
and determination of CRP and IgE concentrations were performed to investigate if exposure to cigarette smoke
could be linked to the severity of pneumonia.
Results: Exposure to cigarette smoke in infants changed the likelihood of the severity of pneumonia. The results
suggest a possible link between the duration of clinical manifestation of pneumonia within infants that are exposed
to cigarette smoke. Infants who are exposed to cigarette smoke had higher plasma concentrates in both IgE and
CRP. Among infants with the mutant variant of the TNF-α (G-308A) gene, infants from households where both
parents smoked or had a father who smoked had longer duration of clinical signs of pneumonia than did infants with
no exposure to tobacco smoke. The plasma concentration of IgE in infants in families where one or both parents
smoke was significantly higher than in infants with no smoke exposure.
Conclusion: The study begins to develop evidence that if the newborn infant is exposed to tobacco smoke either
directly from their mother or from others in the household including automobiles, the severity of pneumonia is
increased. Both nurses and pediatricians should reinforce the consequences of smoke around the baby to all
parents at every opportunity.
Keywords: Passive smoking; Mother smoking; Modulate cytokines;
Infants; Pneumonia
Introduction
Tobacco smoking has a pronounced toxic effect on the human body.
The increase in the prevalence of smoking among women is a human
tragedy because smoking not only adversely affects the woman herself:
if she smokes during pregnancy it also affects the health of future
generations. Over the past 10 years in Ukraine, smoking prevalence
among the female population has tripled, which leads to pathology in
pregnancy and childbirth, and unassociated increase in perinatal
mortality and morbidities in infants [1-4].
Globally, about 40% of children are exposed to the harmful effects of
passive smoking. According to a survey conducted in Kiev, 49% of
children suffer from exposure to tobacco smoke at home and 71% are
exposed to tobacco smoke in public places [5]. The presence of
smokers in the family is a risk factor for intrauterine damage to fetal
endothelium and, as a consequence, lung disease in the postnatal
period of the child’s development [6]. Secondhand exposure to smoke
is also a very significant risk factor for sudden infant death syndrome
[7,8].
A previous study investigated the probability of hospitalization for
respiratory diseases in 4486 infants whose mothers smoked. Compared
with the absolute risk of hospitalization for children whose parents had
never smoked in rooms where the child was present, the absolute risk
of hospitalization for children with a smoking parent present in the
room was 56% higher than if never been exposed to tobacco smoke. If
the mother smoked while holding the baby in her arms, the risk
increased to 73% great than the clean air infant. If the mother smoked
while breastfeeding the baby, the risk of hospitalization increased to
95% [9-11].
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The higher frequency of respiratory diseases in these children can,
in part, be explained by the mucous membranes of the upper
respiratory tract being most affected by the toxins in tobacco smoke
[12,13]. The cytomorphological and functional integrity of these
membranesis animportant element of the first line of defense against
the effectsof unfavorable environmental factors associated with
exposure to tobacco smoke [14-16]. Tobacco smoke can trigger allergic
sensitization that directly affects immunoglobulin-E at the cellular
level and can increase the permeability of the epithelium of the
airways, further reducing its function as a protective barrier [17-19].
Cytokines are important in the communication between the
immune system and other cells involved in the immune response, and
the cytokines C-reactive protein (CRP) and tumor necrosis factor
(TNF-α) play a central role in the regulation of inflammatory
responses [20,21]. Thus the concentration of these cytokines in the
blood can indicate the functional activity of various types of immune
cells, the severity of inflammation, its transition to a system level, and
the prognosis [22]. Tobacco smoke is known to increase the content of
inflammatory mediators in endothelial cells. Blood levels of C-reactive
protein, TNF-α, anti-inflammatory cytokine (IL-4), and inflammatory
cytokines IL-6 and IL-8 are also increased [23]. These changes in
cytokine concentrations may increase the risk and severity of
pneumonia. Thus young children exposed to tobacco smoke may be at
increased risk of severe pneumonia.
The molecular–genetic mechanisms that modulate cytokine status
have not been studied in infant passive smokers with pneumonia of
various severities. Specifically, the relationship between
polymorphisms of the genes for cytokine IL-4 (C-589T) and TNF-α
(G-308A) and severe pneumonia in infant passive smokers is
unknown. The IL-4 gene is involved in the immune response: it plays
an important role in the interaction of cellular and humoral immune
factors and inflammatory reactions. The most important functional
polymorphism of the IL-4 gene is C-589T. This gene polymorphism is
the most studied the most common and the most informative.
A human may have following variants of IL-4 (C-589T): C/C – the
normal variant in homozygous form; C/T – the heterozygous variant;
and T/T – the mutated variant, which is associated with increased risk
of disease in the homozygous form. The international databases
HuGEN and Gene Cards provide information on the various
polymorphisms of theTNF-α gene and their possible association with
inflammatory autoimmune diseases and malignant and benign tumors.
The most widespread polymorphism of the TNF-α gene is G308–A.
human may have following variants of TNF-α (G-308A): G/G – the
normal variant in homozygous form; G/A – the heterozygous variant;
and A/A – the mutated variant.
Objectives
The purpose of the study was to investigate in a cross sectional
manner the role of genetic polymorphism of IL-4 (C-589T) and TNF-α
(G-308A) and regular passive smoking in clinical manifestations of
pneumonia in infants. Specifically, we sought to (i) determine the
frequency of polymorphism in two genetic determinants of the
inflammatory response [IL-4 (C-589T) and TNF-α (G-308A)] among a
population of infants with pneumonia, and (ii) investigate the effects of
passive smoking on the severity of pneumonia in these infants in the
context of the relationship with both the genetic variants of IL-4
(C-589T) and TNF-α (G-308A)and plasma levels of IgE and CRP.
Methods
The project was approved by the Ethics Committee of the Odessa
Regional Children’s Clinical Hospital. Children of the 1st year of life:
from 28 days to 1 year (150) with pneumonia of various severities were
recruited representing 76.5% of all infants with pneumonia admitted to
the pediatric department of the hospital. Woman were eligible if they
could read the informed consent, agreed to participate, were willing to
let the investigators to take blood from the infant for the purpose of the
study, and allow investigators to collect recorded data from the mother
and infants medical records. The severity of pneumonia was classified
according to the system adopted by the 12th Congress of Pediatricians
of Ukraine.
The infants in this cross sectional study were categorized into three
groups:
1. Infant passive smokers (50) whose mothers smoked.
2. Infant passive smokers (50) whose mothers did not smoke, but
who were exposed to tobacco smoke from other relatives in the family.
3. Infants (50) in families in which no-one smoked.
To determine the level of IgE and CRP were used a biomaterial -
blood serum. Levels of IgE and CRP have been carried out by immune
turbidimetric method using the analyzer Cobas 6000. To determine
gene polymorphism were used a biomaterial - buccal scraping.
Molecular genetic studies have been carried out by polymerase chain
reaction. Analysis of genetic polymorphisms (regional frequencies)
and determination of CRP and IgE concentrations were performed in
the German research center HERMEDTEH in Odessa, Ukraine.
Statistical Analysis
The data were processed using statistical software (STATISTICA
7.0) [24,25] and the statistical component of Microsoft Excel TM 2003;
with the integration program Atte Stat 13.5, Internet-calculator SISA
(Simple Interactive Statistical Analysis). Descriptive statistics (mean,
95% confidence intervals) are presented for the frequencies of genetic
variants. Duration of clinical manifestations of pneumonia are
presented as mean ± standard error of mean (SEM). In all procedures
when testing the null hypotheses, the critical level of significance (P)
was set at 05. Three methods were used to check for normal
distribution: graphics, Kolmogorov-Smirnov tests and Shapiro-Wilkie
tests. The relationship between pairs of discrete quantitative variables
as examined by analysis of paired contingency tables, where the
estimated values of the statistic Pearson’s chi-square (χ2) achieved the
level of significance (P) and odds ratio (OR) with 95% Confidence
intervals.
Results
We have studied the regional frequency of gene polymorphisms IL-4
(C-589T) and TNF-α (G-308A) among 150 infants who were
hospitalized to the pediatric department of the Odessa Regional
Children's Hospital (N/150).
The frequency of IL-4 (C-589T) gene variants among infants
differed significantly (Table 1). The heterozygous variant (C/T) was
more frequent than the mutant variant (T/T) (OR=2.98, 95% CI
1.78-4.98). The normal variant (C/C) was also more frequent than the
mutant variant (T/T) (OR=2.38, 95% CI 1.42-4.01).
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IL-4(C-589T) Gene
Polymorphism
The detection rate in the sample
n-=150
(n/%) (95%Cl)
C/C
56/37a
(22.36-51.15)
C/T
64/43a
(31.34-55.15)
T/T
30/20
(10.18-34.4
a Significant different in groups (p<0.05)
Table 1: Distribution of infants depends on different variants of IL-4
(C-589T) gene polymorphism.
TNF-α (G-308A) gene polymorphism
The detection rate in the
sample
n=150
(n/%) (95%Cl)
G/G
62/41a
(28.93-51.6)
G/A
74/49a
(38.14-59.12)
A/A
14/9
(3.79-21.18)
aSignificant different in groups (p<0.05)
Table 2: Distribution of infants depends on different variants of TNF-α
(G-308A) gene polymorphism.
The frequency of TNF-α (G-308A) gene variants among infants also
differed significantly (Table 2). The normal variant (G/G) was more
frequent than the mutant variant (A/A)(OR=6.84, 95 % CI 3.61-12.97).
The heterozygous variant (G/A) was also more frequent than the
mutant variant (A/A)(OR=9.46, 95% CI 5.01-17.88).
The average duration of clinical manifestations of pneumonia in
infants with the normal and heterozygous variants of the IL-4
(C-589T) gene was longer in infants in families where one or both
parents smoked than in infants with no smoke exposure (Table 3).
Similarly, the average duration of clinical manifestations of pneumonia
in infants with the normal and heterozygous variants of the TNF-α
(G-308A) gene was longer in infants in families where one or more
parents smoked than in infants in families with no smoke exposure
(Table 4). In infants with the mutant variant of the IL-4 (C-589T) gene,
there were no significant differences in duration of clinical signs
between infant passive smokers and infants with no smoke exposure
(Table 3). However, among infants with the mutant variant of the TNF-
α (G-308A) gene, infants from households where both parents smoked
or had a father who smoked had longer duration of clinical signs than
did infants with no exposure (Table 4).
IL-4(C-589T)
gene
polymorphism
The duration of clinical manifestations of pneumonia
Both parents are
smokers (n=50)
Only father is a
smoker (n=50)
No exposure
(n=50)
Mean ± SEM Mean ± SEM Mean ± SEM
C/C 15.46 ± 2.12а 12.23 ± 1.87а 7.27 ± 0.72
C/T 20.21 ± 3.25а 16.07 ± 2.36а 10.04 ± 1.22
T/T 24.04 ± 2.56 22.36 ± 2.01 20.07 ± 1.73
aSignificant different in groups (p<0.05)
Table 3: The average duration of clinical manifestations of pneumonia
in infants, depending on degree of cigarette smoke exposure in the
family and identified IL-4 (C-589T) gene polymorphisms.
TNF-α (G-308A) gene polymorphism
The duration of clinical manifestations of pneumonia
Both parents are smokers (n=50) Only father is a smoker(n=50) No exposure (n=50)
Mean ± SEM Mean ± SEM Mean ± SEM
G/G 14.25 ± 2.32а 13.12 ± 1.37а 8.32 ± 0.64
G/A 20.31 ± 3.46а 17.08 ± 3.12а 11.12 ± 1.43
A/A 25.13 ± 3.57а 19.48 ± 1.89 17.59 ± 1.84
aSignificant different in groups (p<0.05)
Table 4: The average duration of clinical manifestations of pneumonia in infants, depending on degree of cigarette smoke exposure in the family
and identified TNF-α (G-308A) gene polymorphisms.
The plasma concentration of IgE in infants in families where one or
both parents smoke was significantly higher than in infants with no
smoke exposure. The concentration of CRP in infants in families where
both parents smoked was higher than that of both infants in families
where only the father smoked and infants with no smoke exposure
(Table 5).
Discussion
This study provides an analysis of the frequency of IL-4 (C-589T)
and TNF-α (G-308A) gene polymorphisms, and of their association
with clinical manifestations of pneumonia, among infants in the
Odessa region. The findings show that the severity of pneumonia in
infants with normal and heterozygous forms of both the IL-4 (C-589T)
and TNF-α (G-308A) genes are of longer duration in the infants if the
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infant is exposed to tobacco smoke either directly from the mother or
in the presents of other smoking. The differences were not as marked
among infants with the mutant forms of both genes. The results also
suggest a possible link between the duration of clinical manifestations
of pneumonia (within smoking categories) and the presence of the
mutant form of both genes although this was not statistically
demonstrated in the study.
Parameter
Smoking status
Both parents are
smokers (n=50)
Only father is a
smoker(n=50)
No exposure
(n=50)
Mean ± SEM Mean ± SEM Mean ± SEM
IgE (ME/ml) 21.05 ± 2.36а 16.04 ± 1.26а 13.42 ± 0.28
СRP(mg/l) 2.62 ± 0.87а 1.24 ± 0.42 0.31 ± 0.25
a Significant different in groups (p<0.05)
Table 5: Levels of IgE and СRP in relation to degree of cigarette smoke
exposure (Mean ± SEM).
In addition, the results showed that infant passive smoking is
associated with higher plasma concentrations of both IgE and CRP.
This was most marked in infants whose parents both smoked and lead
to a more severe course of pneumonia.
The observed frequencies of the variants of the IL-4 (C-589T) and
TNF-α (G-308A) genes in this population of infants with respiratory
diseases corresponds to those found in other studies [1,7].
New data on the effects of passive smoking and efficiency of
predicting the severity of acute pneumonia in infants who are exposed
to passive smokers can improve the results of diagnostics, treatment
and prevention of respiratory diseases in children. If the clinician
knows the infant is exposed to tobacco smoke in the home, a most
aggressive treatment may be the better course of action. The severity of
pneumonia will be greater for infants coming from households where
tobacco smoke is in the environment.
This study provides a strong case that all parents at the birth of their
child should be made aware of the direct consequences of their
smoking to their new baby. Both nurses and pediatricians should
reinforce this information of the consequences of smoke around the
baby to the parents on every visit to a clinic for well-baby checkups. It
is the duty of health care practitioners to encourage mothers to quit
smoking during pregnancy and to encourage them to remain non-
smoking for the health of their infants. This is currently not the
practice of doctors [26]. Further pediatricians in training should be
provided a greater education on the harmful effects of tobacco
smoking to the fetus and new born infant. This additional training
should include how to discuss and plan a smoke free environment for
the infant with their patients.
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